NCT04812509 2023-02-24Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid TumorsMabwell (Shanghai) Bioscience Co., Ltd.Phase 3 Completed708 enrolled
NCT04550949 2020-09-22To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 3 Unknown700 enrolled